Karl Bayer

Title: The Innovations of Karl Bayer

Introduction

Karl Bayer is a notable inventor based in Vienna, Austria. He is recognized for his contributions to the field of biotechnology, particularly in the development of expression vectors. His work has significant implications for the production of recombinant proteins.

Latest Patents

Karl Bayer holds a patent titled "Expression vectors with modified ColE1 origin of replication for control of plasmid copy number." This patent involves an expression vector that utilizes a ColE1 replication system. The innovation includes modifications to the homology of the RNAI and RNAII of the ColE1 origin of replication through mutations in the coding region of the RNAI gene and corresponding mutations in the RNAII gene. These mutations lead to base exchanges in specific loops of RNAI and RNAII. The methods utilizing this vector allow for stable maintenance of plasmid copy number and enable high plasmid copy numbers during plasmid production.

Career Highlights

Karl Bayer is associated with Boehringer Ingelheim International GmbH, where he has made significant contributions to the field of biotechnology. His work has been instrumental in advancing the understanding and application of expression vectors in recombinant protein production.

Collaborations

Some of his notable coworkers include Reingard Grabherr and Erik Nilsson. Their collaborative efforts have further enhanced the research and development in the field.

Conclusion

Karl Bayer's innovative work in the development of expression vectors has made a lasting impact on biotechnology. His patent reflects a significant advancement in the control of plasmid copy number, which is crucial for the efficient production of recombinant proteins.